Effect of caffeine ingestion on exhaled nitric oxide measurements in patients with asthma.
Exhaled nitric oxide (FENO) measurements may be influenced by a number of confounding factors. Reports have offered conflicting evidence as to whether caffeine consumption increases or decreases FENO. In this study we aimed to confirm whether caffeine ingestion affects FENO in patients with asthma. On two separate days, 20 patients with asthma (10 steroid-naive and 10 steroid-treated) received a standard cup of either caffeinated or noncaffeinated coffee (15 g) (control) in a randomized, double-blind, cross-over manner. FENO measurements were obtained at baseline, and 30, 60, 120, and 180 minutes after ingestion. Serum caffeine levels were also measured at 0 and 60 minutes. No significant changes in FENO occurred after caffeine compared with the control. We conclude that caffeinated foods and beverages are unlikely to acutely influence FENO in subjects with asthma, and protocols for laboratory measurement do not need to take this factor into account.
Otago Respiratory Research Unit, Dunedin School of Medicine, University of Otago Medical School, Dunedin, New Zealand.
Elizabeth S
ES
Taylor
Andrew D
AD
Smith
Jan O
JO
Cowan
G Peter
GP
Herbison
D Robin
DR
Taylor
D000284:Administration, Oral; D000293:Adolescent; D000328:Adult; D000368:Aged; D000704:Analysis of Variance; D018927:Anti-Asthmatic Agents / Q000627:therapeutic use; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D001249:Asthma / Q000175:diagnosis* / Q000188:drug therapy / Q000378:metabolism; D001507:Beclomethasone / Q000627:therapeutic use; D015982:Bias; D001944:Breath Tests / Q000379:methods*; D002110:Caffeine / Q000008:administration & dosage* / Q000378:metabolism; D015986:Confounding Factors, Epidemiologic; D018592:Cross-Over Studies; D004311:Double-Blind Method; D005247:Feeding Behavior; D005541:Forced Expiratory Volume; D006801:Humans; D008657:Metabolic Clearance Rate; D008875:Middle Aged; D009569:Nitric Oxide / Q000032:analysis*; D012680:Sensitivity and Specificity; D013997:Time Factors
D018927:Anti-Asthmatic Agents; D000893:Anti-Inflammatory Agents; D009569:Nitric Oxide; D002110:Caffeine; D001507:Beclomethasone